Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for FERRIC CARBOXYMALTOSE
- Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
- The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
- Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion
- Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
- Impact of Intravenous Iron on Musculoskeletal Function in Older Adults
- Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
- Iron Substitution With Ferric Carboxymaltose as Treatment Strategy for Heart Failure Patients With Preserved Ejection Fraction
- Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery
- Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial
- An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
- IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department
- Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
- Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia
- Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding
- Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
- Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
- Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting
- IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI
- Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
- Preoperative i.v. Iron Substitution in Patients With Colon Cancer
- Do Iron And Vitamin B12 Injections Given Together, Improve Hemoglobin In Patients On Hemodialysis?
- Perioperative Management in Gynaecological Carcinoma Surgery
- Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
- Clinical Burden of Anemia in Inflammatory Bowel Disease: Therapeutic Trial
- Iron Deficiency as an Ignored Cause of Infertility
- Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD)
- Effect of Ultra-short-term Treatment of Patients With Iron Deficiency or Anemia Undergoing Adolescent Scoliosis Correction
- Neurovascular Complications and White Matter Damage in Acquired Anemias
- Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
- Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia
- Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy
- Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer
- Transfusion Savings in Heart Surgery: Impact of Individual Strategy by Erythropoietin and Metabolic Adjustment (ScvO2)
- Polyglucoferron Compared to i.v. Ferric Carboxymaltose and Oral Iron Substitution in Preoperative Treatment of Iron Deficiency Anaemia in Patients
- Impact of Intravenous Iron Treatment of Preoperative Anemia in Patients With LEAD (IRONPAD)
- Intraoperative IV Iron on Postoperative Red Blood Cell Recovery
- Iron in Patients With Cardiovascular Disease
- Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
- Ferric Carboximaltose on Intra-myocardial Iron Load in Patients With Heart Failure
- Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency
- Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency
- Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient
- Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation
- Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
- Postoperative Replacement of Intraoperative Iron Losses
- Intravenous Iron in Adults With Cystic Fibrosis
- To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
- Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
- Effect of Preoperative Ferric Carboxymaltose After Simultaneous Bilateral Total Knee Arthroplasty
- Effect of Postoperative Ferric Carboxymaltose
- Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA
- A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
- A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia
- Changes in Myocardial Iron After Iron Administration
- Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD
- Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy
- Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
- Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
- Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child
- Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
- A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.
- Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
- Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
- Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial
- Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
- Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
- The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery
- Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
- A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
- Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
- Intravenous Iron Pre-treatment in Prognathic Surgery
- A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
- Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
- Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy
- IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania
- Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
- Cross Iron (Comparative Randomized Oral Versus Systemic IRON)
- Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.
- Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®
- A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA
- Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
- Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS
- Iron Status and Human Metabolism
- Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia
- Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
- Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
- Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients
- A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
- Intravenous Iron: Measuring Response in Anemic Surgical Patients
- Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.
- Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill
- Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose
- The Use of Iron Therapy for Patients With Anemia After Surgery
- Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
- Comparing Intravenous and Oral Iron in Postoperative Anemia
- Iron in Congestive Heart Failure
- Intravenous High Dose Iron in Blood Donors
- Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)
- IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia
- Preoperative Intravenous Iron to Treat Anaemia in Major Surgery
- Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
- A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
- Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
- Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
- Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
- Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
- Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
- Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
- Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period
- Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
- Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
- Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
- Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
- Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
- Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
- Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
- Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
- EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
- FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
- Maintenance Treatment of Iron Deficiency in IBD Patients
- Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
- Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
- Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
- Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
- Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients
- Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
Clinical trials list
click for details